SEC Tracker
Get the app

SI-BONE SIBN

Laura Francis (CEO) sold 75,000 SIBN at $25.30, worth $1.9M, under a 10b5-1 plan

Form
4
Filed
Importance
Routine
  1. Laura Francis sold 75,000 shares at $25.30
  2. Shares held by trust after sale: 304,256
  3. Includes 355,697 shares from restricted stock units (shares paid out over time)

Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when SI-BONE files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Biolife Solutions BLFS public float $845M, Jun 30, 2025
  2. Embecta EMBC public float $732M, Mar 31, 2025, over 18 months old
  3. Mimedx Group MDXG public float $719M, Jun 30, 2025
  4. Heartflow HTFL
  5. Integra Lifesciences Holdings IART public float $925M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.